{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:52:52Z","timestamp":1777931572850,"version":"3.51.4"},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"3","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHDDT"],"published-print":{"date-parts":[[2020,11,26]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>HIV-positive patients have a 60- to 200-fold increased incidence of Non-Hodgkin\nLymphomas (NHL) because of their impaired cellular immunity. Some NHL are considered\nAcquired Immunodeficiency Syndrome (AIDS) defining conditions. Diffuse large B-cell Lymphoma\n(DLBC) and Burkitt Lymphoma (BL) are the most commonly observed, whereas Primary Effusion\nLymphoma (PEL), Central Nervous System Lymphomas (PCNSL), Plasmablastic Lymphoma (PBL)\nand classic Hodgkin Lymphoma (HL) are far less frequent. Multicentric Castleman disease (MCD)\nis an aggressive lymphoproliferative disorder highly prevalent in HIV-positive patients and strongly\nassociated with HHV-8 virus infection. In the pre-Combination Antiretroviral Therapy (CART) era,\npatients with HIV-associated lymphoma had poor outcomes with median survival of 5 to 6 months.\nBy improving the immunological status, CART extended the therapeutic options for HIV positive\npatients with lymphomas, allowing them to tolerate standard chemotherapies regimen with similar\noutcomes to those of the general population. The combination of CART and chemotherapy\/\nimmuno-chemotherapy treatment has resulted in a remarkable prolongation of survival among HIVinfected\npatients with lymphomas. In this short communication, we briefly review the problems\nlinked with the treatment of lymphoproliferative diseases in HIV patients. Combination\nAntiretroviral Therapy (CART) not only reduces HIV replication and restores the immunological\nstatus improving immune function of the HIV-related lymphomas patients but allows patients to\ndeal with standard doses of chemotherapies. The association of CART and chemotherapy allowed\nto obtain better results in terms of overall survival and complete responses. In the setting of HIVassociated\nlymphomas, many issues remain open and their treatment is complicated by the patient\u2019s\nimmunocompromised status and the need to treat HIV concurrently.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871529x20666200415121009","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T17:51:06Z","timestamp":1586973066000},"page":"175-180","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy"],"prefix":"10.2174","volume":"20","author":[{"given":"Roberto","family":"Castelli","sequence":"first","affiliation":[{"name":"Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Luigi Sacco Hospital Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Schiavon","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Luigi Sacco Hospital Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Preti","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Luigi Sacco Hospital Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurenzia","family":"Ferraris","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Hospital Health Direction, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/QAI.0b013e31817efb54","volume":"48","author":"Lewden C.","year":"2008","unstructured":"Lewden C.; May T.; Rosenthal E.; Burty C.; Bonnet F.; Costagliola D.; Jougla E.; Semaille C.; Morlat P.; Salmon D.; Cacoub P.; Ch\u00eane G.; ANRS EN19 Mortalit\u00e9 Study Group and Mortavic1. Changes in causes of death among adults infected by HIV between 2000 and 2005: The \u201cMortalit\u00e9 2000 and 2005\u201d surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008,48(5),590-598","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0140-6736(91)92513-2","volume":"337","author":"Beral V.","year":"1991","unstructured":"Beral V.; Peterman T.; Berkelman R.; Jaffe H.; AIDS-associated non-Hodgkin lymphoma. Lancet 1991,337(8745),805-809","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","volume":"98","author":"Besson C.","year":"2001","unstructured":"Besson C.; Goubar A.; Gabarre J.; Rozenbaum W.; Pialoux G.; Ch\u00e2telet F.P.; Katlama C.; Charlotte F.; Dupont B.; Brousse N.; Huerre M.; Mikol J.; Camparo P.; Mokhtari K.; Tulliez M.; Salmon-C\u00e9ron D.; Bou\u00e9 F.; Costagliola D.; Rapha\u00ebl M.; Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001,98(8),2339-2344","journal-title":"Blood"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1182\/blood-2010-07-290213","volume":"116","author":"Bower M.","year":"2010","unstructured":"Bower M.; How I treat HIV-associated multicentric Castleman disease. Blood 2010,116(22),4415-4421","journal-title":"Blood"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/annonc\/mdn697]","volume":"20","author":"Powles T.","year":"2009","unstructured":"Powles T.; Stebbing J.; Bazeos A.; Hatzimichael E.; Mandalia S.; Nelson M.; Gazzard B.; Bower M.; The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman\u2019s disease. Ann Oncol 2009,20(4),775-779","journal-title":"Ann Oncol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1182\/asheducation-2013.1.382","volume":"2013","author":"Little R.F.","year":"2013","unstructured":"Little R.F.; Dunleavy K.; Update on the treatment of HIV-associated hematologic malignancies. Hematology (Am Soc Hematol Educ Program) 2013,2013,382-388","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x]","volume":"130","author":"Carbone A.","year":"2005","unstructured":"Carbone A.; Gloghini A.; AIDS-related lymphomas: From pathogenesis to pathology. Br J Haematol 2005,130(5),662-670","journal-title":"Br J Haematol"},{"key":"ref=8","first-page":"431","volume":"27","author":"Gaidano G.","year":"2000","unstructured":"Gaidano G.; Capello D.; Carbone A.; The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis. Semin Oncol 2000,27(4),431-441","journal-title":"Semin Oncol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nrmicro2712","volume":"10","author":"Barber D.L.","year":"2012","unstructured":"Barber D.L.; Andrade B.B.; Sereti I.; Sher A.; Immune reconstitution inflammatory syndrome: The trouble with immunity when you had none. Nat Rev Microbiol 2012,10(2),150-156","journal-title":"Nat Rev Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1001\/archinte.163.18.2187","volume":"163","author":"Kaufmann G.R.","year":"2003","unstructured":"Kaufmann G.R.; Perrin L.; Pantaleo G.; Opravil M.; Furrer H.; Telenti A.; Hirschel B.; Ledergerber B.; Vernazza P.; Bernasconi E.; Rickenbach M.; Egger M.; Battegay M.; CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med Swiss HIV Cohort Study Group2003,163(18),2187-2195","journal-title":"Arch Intern Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/hon.2575","volume":"37","author":"Rattotti S.","year":"2019","unstructured":"Rattotti S.; Ferretti V.V.; Rusconi C.; Rossi A.; Fogazzi S.; Baldini L.; Pioltelli P.; Balzarotti M.; Farina L.; Ferreri A.J.M.; Laszlo D.; Speziale V.; Varettoni M.; Sciarra R.; Morello L.; Tedeschi A.; Frigeni M.; Defrancesco I.; Zerbi C.; Flospergher E.; Nizzoli M.E.; Morra E.; Arcaini L.; \u201cRete Ematologica Lombarda\u201d (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup). Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network. Hematol Oncol 2019,37(2),160-167","journal-title":"Hematol Oncol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","volume":"128","author":"Spina V.","year":"2016","unstructured":"Spina V.; Khiabanian H.; Messina M.; Monti S.; Cascione L.; Bruscaggin A.; Spaccarotella E.; Holmes A.B.; Arcaini L.; Lucioni M.; Tabb\u00f2 F.; Zairis S.; Diop F.; Cerri M.; Chiaretti S.; Marasca R.; Ponzoni M.; Deaglio S.; Ramponi A.; Tiacci E.; Pasqualucci L.; Paulli M.; Falini B.; Inghirami G.; Bertoni F.; Fo\u00e0 R.; Rabadan R.; Gaidano G.; Rossi D.; The genetics of nodal marginal zone lymphoma. Blood 2016,128(10),1362-1373","journal-title":"Blood"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/path.5209","volume":"247","author":"Xochelli A.","year":"2019","unstructured":"Xochelli A.; Bikos V.; Polychronidou E.; Galigalidou C.; Agathangelidis A.; Charlotte F.; Moschonas P.; Davis Z.; Colombo M.; Roumelioti M.; Sutton L.A.; Groenen P.; van den Brand M.; Boudjoghra M.; Algara P.; Traverse-Glehen A.; Ferrer A.; Stalika E.; Karypidou M.; Kanellis G.; Kalpadakis C.; Mollejo M.; Pangalis G.; Vlamos P.; Amini R.M.; Pospisilova S.; Gonzalez D.; Ponzoni M.; Anagnostopoulos A.; Giudicelli V.; Lefranc M.P.; Espinet B.; Panagiotidis P.; Piris M.A.; Du M.Q.; Rosenquist R.; Papadaki T.; Belessi C.; Ferrarini M.; Oscier D.; Tzovaras D.; Ghia P.; Davi F.; Hadzidimitriou A.; Stamatopoulos K.; Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations. J Pathol 2019,247(4),416-421","journal-title":"J Pathol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12032-018-1183-7","volume":"35","author":"Sbattella M.","year":"2018","unstructured":"Sbattella M.; Zanichelli A.; Ghia P.; Gattei V.; Suffritti C.; Teatini T.; Cicardi M.; Castelli R.; Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: Clinical and molecular characterization. Med Oncol 2018,35(9),118","journal-title":"Med Oncol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bjh.13908","volume":"172","author":"Castelli R.","year":"2016","unstructured":"Castelli R.; Wu M.A.; Arquati M.; Zanichelli A.; Suffritti C.; Rossi D.; Cicardi M.; High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency. Br J Haematol 2016,172(6),902-908","journal-title":"Br J Haematol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood.V84.2.397.397","volume":"84","author":"Gaidano G.","year":"1994","unstructured":"Gaidano G.; Lo Coco F.; Ye B.H.; Shibata D.; Levine A.M.; Knowles D.M.; Dalla-Favera R.; Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin\u2019s lymphoma: Association with diffuse large-cell subtype. Blood 1994,84(2),397-402","journal-title":"Blood"},{"key":"ref=17","first-page":"3755","volume":"89","author":"Gaidano G.","year":"1997","unstructured":"Gaidano G.; Carbone A.; Pastore C.; Capello D.; Migliazza A.; Gloghini A.; Roncella S.; Ferrarini M.; Saglio G.; Dalla-Favera R.; Frequent mutation of the 5\u2032 noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin\u2019s lymphomas. Blood 1997,89(10),3755-3762","journal-title":"Blood"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1182\/blood-2018-01-791400","volume":"134","author":"Noy A.","year":"2019","unstructured":"Noy A.; Optimizing treatment of HIV-associated lymphoma. Blood 2019,134(17),1385-1394","journal-title":"Blood"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.dld.2016.08.113","volume":"48","author":"Castelli R.","year":"2016","unstructured":"Castelli R.; Ferraris L.; Pantaleo G.; Lambertenghi Deliliers G.; Cicardi M.; High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy. Dig Liver Dis 2016,48(11),1394-1397","journal-title":"Dig Liver Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/jac\/dki050","volume":"55","author":"Cruciani M.","year":"2005","unstructured":"Cruciani M.; Gatti G.; Vaccher E.; Di Gennaro G.; Cinelli R.; Bassetti M.; Tirelli U.; Bassetti D.; Pharmacokinetic interaction between chemotherapy for non-Hodgkin\u2019s lymphoma and protease inhibitors in HIV-1-infected patients. J Antimicrob Chemother 2005,55(4),546-549","journal-title":"J Antimicrob Chemother"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","volume":"94","author":"Sandherr M.","year":"2015","unstructured":"Sandherr M.; Hentrich M.; von Lilienfeld-Toal M.; Massenkeil G.; Neumann S.; Penack O.; Biehl L.; Cornely O.A.; Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol 2015,94(9),1441-1450","journal-title":"Ann Hematol"},{"key":"ref=22","first-page":"3150","volume":"34","author":"Schmitz N.","year":"2016","unstructured":"Schmitz N.; Zeynalova S.; Nickelsen M.; CNS International Prognostic Index: A Risk Model CT scanning of the chest, abdomen and pelvis and MRI of the head should be performed. Oncol 2016,34,3150-3156","journal-title":"Oncol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbmt.2004.09.009","volume":"11","author":"Kasamon Y.L.","year":"2005","unstructured":"Kasamon Y.L.; Jones R.J.; Piantadosi S.; Ambinder R.F.; Abrams R.A.; Borowitz M.J.; Morrison C.; Smith B.D.; Flinn I.W.; High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Biol Blood Marrow Transplant 2005,11(2),93-100","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","volume":"122","author":"Barta S.K.","year":"2013","unstructured":"Barta S.K.; Xue X.; Wang D.; Tamari R.; Lee J.Y.; Mounier N.; Kaplan L.D.; Ribera J.M.; Spina M.; Tirelli U.; Weiss R.; Galicier L.; Boue F.; Wilson W.H.; Wyen C.; Oriol A.; Navarro J.T.; Dunleavy K.; Little R.F.; Ratner L.; Garcia O.; Morgades M.; Remick S.C.; Noy A.; Sparano J.A.; Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood 2013,122(19),3251-3262","journal-title":"Blood"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1200\/JCO.2005.05.4684","volume":"24","author":"Bou\u00e9 F.","year":"2006","unstructured":"Bou\u00e9 F.; Gabarre J.; Gisselbrecht C.; Reynes J.; Cheret A.; Bonnet F.; Billaud E.; Raphael M.; Lancar R.; Costagliola D.; Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin\u2019s lymphoma. J Clin Oncol 2006,24(25),4123-4128","journal-title":"J Clin Oncol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/QAD.0b013e32834f30fa","volume":"26","author":"Wyen C.","year":"2012","unstructured":"Wyen C.; Jensen B.; Hentrich M.; Siehl J.; Sabranski M.; Esser S.; Gillor D.; M\u00fcller M.; Van Lunzen J.; Wolf T.; Bogner J.R.; Wasmuth J.C.; Christ H.; F\u00e4tkenheuer G.; Hoffmann C.; Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients. AIDS 2012,26(4),457-464","journal-title":"AIDS"}],"container-title":["Cardiovascular &amp; Hematological Disorders-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/180910","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/180910\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/180910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T13:02:18Z","timestamp":1640178138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/180910\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,11,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871529x20666200415121009","relation":{},"ISSN":["1871-529X"],"issn-type":[{"value":"1871-529X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-08-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}